Piek, A., Koonen, D. P. Y., Schouten, E., Lindtstedt, E. L., Michaëlsson, E., de Boer, R. A., & Silljé, H. H. W. (2019). Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. Sci Rep.

Piek, Arnold, Debby P. Y. Koonen, Elisabeth-Maria Schouten, Eva L. Lindtstedt, Erik Michaëlsson, Rudolf A. de Boer, and Herman H. W. Silljé. "Pharmacological Myeloperoxidase (MPO) Inhibition in an Obese/hypertensive Mouse Model Attenuates Obesity and Liver Damage, but Not Cardiac Remodeling." Sci Rep 2019.

Piek, Arnold, et al. "Pharmacological Myeloperoxidase (MPO) Inhibition in an Obese/hypertensive Mouse Model Attenuates Obesity and Liver Damage, but Not Cardiac Remodeling." Sci Rep 2019.